Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
About Two River Group
Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products. Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
Tyana F. Kurtz, Director Marketing

Ms. Kurtz currently serves as the Director of Marketing at Two River. She is responsible for all marketing related activities at Two River and provides marketing support to its portfolio companies. Prior to joining Two River, from August 2003 until February 2006, Ms. Kurtz served as Senior Marketing Manager in the Cardiovascular Group of Pfizer, Inc., where she co-led and co-implemented the U.S. launch of a novel heart failure compound.

Prior to joining Pfizer, Ms. Kurtz was a Manager in the health care practice of Deloitte Consulting, where she focused on strategic planning and business development for major healthcare organizations.

Ms. Kurtz received her B.A. degree in Biology from Middlebury College and her M.B.A. degree from Columbia Business School.


Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.		 Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
© 2008 Two River Group Holdings, LLC | Terms of Use | Privacy Policy
Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.